EryonStudio, healthcare motion design studio
Our films, the method, the communication kit and the process, from idea to final version.
EryonStudio
Uses
Disease awareness video
Disease awareness video: informing without promoting
A disease awareness video makes a disease known to the general public: its mechanisms, its signs, its diagnosis and the care options, presented on an equal footing. EryonStudio, Eryon's video studio in Lille, France, makes it for patient organisations, healthcare providers, medical societies, mutual health insurers and health companies, with a first version within a few days. It names no product or brand, and every line shows its source on screen.
The video at a glance
- Audience General public and patientsShown by a patient organisation, a hospital or a health insurer
- Suggested length About 3 minutesOur awareness films run from 2 min 59 to 4 min 17
- First version Within a few daysUp to 60 seconds, in motion design, in the language you choose
- Evidence Sources on screenEvery line shows its reference while it is spoken
- Quote After the first versionYou judge it on screen before ordering the rest
No product or brand, options on an equal footing, a referral to the doctor
What a disease awareness video shows
It follows the path of someone discovering the disease: understanding it, spotting it, seeing a doctor, knowing the options.
-
Understanding the disease: the mechanism in animation
What happens in the body, at the scale of the organ or the cell, shown in animation rather than in a static diagram. Every line carries one idea, and every technical term is explained the first time it appears.
-
An animated health prevention video
The warning signs, screening where it exists, the diagnosis and the test that confirms it, shown as they happen. A risk is stated without alarmism or promises, with a figure and its source when a source gives one.
-
Treatments by family, on an equal footing
Each treatment family or option gets the same time and the same visual treatment, with no efficacy figures, no comparison and no dosage. No product or brand name, including the funder's.
-
A referral to the doctor, at every decision
The video gives no individual advice. Whenever a care decision comes up, it refers the viewer to the doctor, and it ends with an invitation to see one. The statement “For information only, does not replace medical advice” goes with it.
-
A video for your patient organisation
The film carries your organisation's voice: your members' questions, your words, your brand guidelines if you wish, your contact details at the end. We write it with you, and your scientific advisory board can review every source.
-
A disease awareness campaign, in several formats
The main film is adapted for an awareness day, a congress or social media: short excerpts, portrait format, subtitles, other languages. Every excerpt keeps its source and its statements.
Talking about treatments, on an equal footing
This Eryon video, online in French with its line-by-line text and its 16 references, shows that information about a disease can talk about treatments without promoting any: each option has the same place, the choice is made with the medical team and the film ends with a referral to the doctor. During every line, its source appears at the bottom of the screen.
- For
- An Eryon film, health information
- Audience
- General public, couples trying to conceive
- Running time
- 2 min 59
- Justification
- 29 lines, 16 references, 59 exact passages
Five situations, from patient organisation to insurer
The funder and the place where the film is shown change; the content rule stays the same.
A patient organisation preparing an awareness day wants a short, fully referenced film for its social media and its talks.
A hospital wants to raise awareness of a screening test in its waiting rooms, on its website and at reception.
A medical society wants a film for the general public based on its guidelines, every line tied to its source.
A mutual health insurer wants a series of prevention videos for its members, neutral in tone and with no brand.
A pharmaceutical company or a manufacturer wants to fund information about a disease that names none of its products.
Written to remain information, not advertising
Here, scoping starts with the boundary with advertising: who is funding, which treatments exist, which can be named. The options are then written on an equal footing, before the first frame.
- 01
Scoping, in 30 minutes
Objective, audience, where the video will be shown, available references and regulatory points to watch.
- 02
The referenced script
Every line is tied to a reference, with its page and the exact passage that supports it.
- 03
The visuals
Motion design and medical animation, with AI assisting part of the production. Diagrams remain illustrations.
- 04
Checks and delivery
An automated check finds every passage, word for word, on the page cited; two independent AI-assisted audits then re-check a sample in the documents; your review committee, or your MLR review in a pharmaceutical company, approves the final version.
What you receive
Every version keeps the source of its lines and the statement “For information only, does not replace medical advice”, from the main film to the excerpt for social media.
The film and its broadcast files
Landscape for your website, YouTube and the training room; portrait, square or 4:5 for social media.
Subtitles and transcript
SRT file and full text: accessibility, viewing without sound and search visibility for the page that hosts the film.
The script and the justification file
Every line, its reference, its page and the exact passage, ready for your internal review.
The bibliographic references
The full list, in order of appearance, with links to the public sources.
The versions you need
Short excerpts, stills, a poster or slides, depending on your channels. Quoted with the final version.
Languages
The languages you choose: every translated line keeps its source and exact passage, and the rules of the country where the video is shown are checked at scoping.
Informing about a disease without advertising
For a video shown in France, information about a disease stays outside the scope of advertising as long as it makes no reference, even indirect, to a medicine (Article L.5122-1 of the French Public Health Code) or to a medical device (Article L.5213-1). Under the doctrine of the ANSM, the French regulator, it may mention the available treatments, without singling one out; for a device, only the manufacturer's name or logo may appear. A health company that signs an agreement with a patient organisation makes it public in the Transparence Santé database (Article L.1453-1). We apply these rules from the script onwards; final approval is yours.
Frequently asked questions
What is a disease awareness video?
It is an information film that makes a disease known to the general public or to patients: what it is, how it shows itself, how it is detected and what options exist, without promoting anything. It differs from advertising in its content, not its funder: no reference, even indirect, to a medicine or a medical device. It ends with a referral to the doctor.
Can a disease awareness video name a medicine?
Not in a video funded or released by a health company: in France, information about a disease stays outside the scope of advertising as long as it makes no reference, even indirect, to a medicine (Article L.5122-1 of the French Public Health Code), and advertising to the public is in principle prohibited for a prescription-only or reimbursable medicine (Article L.5122-6). The ANSM's doctrine does, however, allow the available treatments to be mentioned and a therapeutic class with more than one medicine to be named, never an international non-proprietary name or a brand name.
How can a video talk about treatments without advertising?
By presenting them on an equal footing: each treatment family or option gets the same time and the same visual treatment, with no efficacy figures, comparison or dosage. If a family contains only one medicine, naming it amounts to naming the product: the video then stays at the level of the mechanism or groups the options together. Every care decision refers to the doctor. Our video on varicocele is an example.
Can a pharmaceutical company fund a patient organisation's video?
Yes, if the video remains information about the disease: no product or brand, options presented on an equal footing, a referral to the doctor. In France, the company discloses the purpose, date and amount of the agreement in the Transparence Santé database, which covers associations of health system users (Article L.1453-1 of the French Public Health Code). We write the script with the organisation, which approves it before any release.
Where can I find reliable health information videos?
On the websites of health authorities, hospitals, medical societies and patient organisations, checking five points: who wrote it and who reviewed it, who funds it, whether every piece of information cites its source, whether no product or brand is put forward, and whether it refers to the doctor for any decision. The publication date also helps you judge. Our videos show the source of every line; no doctor has yet signed off their review.